# COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

> **NCT00814268** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 358 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel placebo
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00814268
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2014-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814268, "COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00814268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*